Metagenomi, Inc. Is Being Sued For Possible Securities Fraud And Impacted Shareholders Are Urged To Reach Out To The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 30, 2024 /The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the federal securities laws.

Investors who purchased the Company 's securities pursuant and/or traceable to the Company 's Offering Documents in connection with its initial public offering ("IPO") conducted on or about February 9, 2024, are encouraged to contact the firm before November 25, 2024.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm 's website at www.schallfirm.com, or by email at bschall@schallfirm.com

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Metagenomi its business relationship with Moderna throughout the IPO period. The Company based its claims on a Strategic Collaboration and License Agreement entered into on October 29, 2021, including multiple four-year research programs and a subsequent licensed product-by-licensed product agreement. The Company announced just months after the IPO that it and Moderna had "mutually agreed to terminate their collaboration." Based on these facts, the Company 's public statements were false and materially misleading throughout the class period. When the market learned the truth about Metagenomi, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View the original press release on accesswire.com

© 2024 Accesswire. All Rights Reserved.